Ascend Collaborates with Stanford University School of Medicine to Study Prevalence of  SARS-CoV-2 Antibodies in the U.S. Dialysis Population

Antibody Test for COVID-19 Now Available

Antibody testing for COVID-19 is now available. Ascend is the first to offer COVID-19 total antibody testing to dialysis clinics, which can be combined with a patient’s regularly scheduled tests without any additional blood draw.
Read More

Ascend, Stanford to study SARS-CoV-2 exposure in patients on dialysis

Ascend to Perform Antibody Testing for COVID-19

Ascend is using the SARS-CoV-2 Total Antibody assay from Siemens Healthineers, performed on high throughput Atellica® Solution immunoassay analyzers.